A PRELIMINARY INVESTIGATION OF THE MANAGEMENT OF ALCOHOL DEPENDENCE WITH NALTREXONE BY PRIMARY-CARE PROVIDERS

Citation
Pg. Oconnor et al., A PRELIMINARY INVESTIGATION OF THE MANAGEMENT OF ALCOHOL DEPENDENCE WITH NALTREXONE BY PRIMARY-CARE PROVIDERS, The American journal of medicine, 103(6), 1997, pp. 477-482
Citations number
29
ISSN journal
00029343
Volume
103
Issue
6
Year of publication
1997
Pages
477 - 482
Database
ISI
SICI code
0002-9343(1997)103:6<477:APIOTM>2.0.ZU;2-9
Abstract
PURPOSE: TO describe a preliminary investigation of a model of naltrex one therapy and counselling for use by primary care providers and eval uate its impact on drinking behaviors in a cohort of alcohol-dependent subjects. PATIENTS AND METHODS: The subjects enrolled in this study w ere 29 alcohol-dependent individuals. They were managed within a prima ry care treatment model located at a university-affiliated substance r esearch program in New Haven, Connecticut. Subjects were assigned to a primary care provider for treatment of their alcohol dependence and w ere placed on naltrexone at a dose of 50 mg per day. They were seen fo r an initial ''new patient'' visit and 7 ''brief'' follow-up visits du ring the 10-week study. The primary outcomes for this study were compl etion of treatment, change in drinking behaviors from baseline, change in liver enzymes from baseline, provider ratings of improvement, and patient ratings of improvement and satisfaction with treatment. RESULT S: Of the 29 subjects: 21 (72%) completed treatment, and 10 (35%) rela psed to heavy drinking. All drinking behaviors improved significantly from baseline: percent of days abstinent increased from 36.6% to 88.8% (P < 0.0001), percent days abstinent from heavy drinking increased fr om 48.7% to 97.3% (P < 0.0001), and mean number of drinks per occasion decreased from 9.5 to 2.5 (P < 0.0001). The mean serum gamma glutamyl transferase (GGT) for the group decreased from 67.1 U/L to 45.3 U/L ( P < 0.0001). CONCLUSIONS: In this preliminary investigation, treatment of alcohol dependence with our model of naltrexone and counselling by primary care providers appeared to be both feasible and effective. (C ) 1997 by Excerpta Medica, Inc.